Abstract

http://ssrn.com/abstract=294471
 
 

References (47)



 
 

Citations (5)



 


 



The Market Valuation of Biotechnology Firms and Biotechnology R&D


John R. M. Hand


University of North Carolina Kenan-Flagler Business School

December 8, 2001


Abstract:     
This paper sheds light on how and why the stock market values high technology by examining the pricing of 606 biotechnology firms that were publicly traded at some time during the period 1989:q1-2000:q3. Contrary to the common view that the primary value drivers of biotechnology are "soft" variables such as intellectual human capital, patents, strategic alliances and joint ventures, I show that simple balance sheet, income statement and statement of cash flows data explains some 70% of the variance in biotech firms' equity market values within a log-linear regression framework. Given the size and economic importance of R&D to biotech firms, I also explore in detail the mapping between the biotech firms' R&D expenditures and equity market values. I hypothesize that the elasticity of equity market value with respect to R&D is a function of five factors: where the R&D lies in the biotech value chain of discovery, development and commercialization; the growth rate in R&D spending; the scale of R&D expenditures; the human capital of the firm's employees; and the age of the firm. Using financial statement proxies for these factors, I find that the elasticity of biotech firms' equity market values with respect to R&D is significantly larger the earlier is the R&D expenditure in the value chain, and the greater is the growth rate in R&D spending. The value elasticity of R&D is also reliably decreasing in the scale of R&D expenditures, and the more mature is the firm. However, it appears unrelated to proxies for both the quantity and quality of employee human capital.

Number of Pages in PDF File: 38

Keywords: Equity valuation; biotechnology; financial statement data; R&D

JEL Classification: G12, M21, M41

working papers series


Download This Paper

Date posted: December 20, 2001  

Suggested Citation

Hand, John R. M., The Market Valuation of Biotechnology Firms and Biotechnology R&D (December 8, 2001). Available at SSRN: http://ssrn.com/abstract=294471 or http://dx.doi.org/10.2139/ssrn.294471

Contact Information

John R. M. Hand (Contact Author)
University of North Carolina Kenan-Flagler Business School ( email )
McColl Building
Chapel Hill, NC 27599-3490
United States
919-962-3173 (Phone)
919-962-4727 (Fax)

Feedback to SSRN


Paper statistics
Abstract Views: 6,523
Downloads: 2,255
Download Rank: 2,794
References:  47
Citations:  5

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo4 in 0.406 seconds